Correlation Between Medigen Biotechnology and PharmaEngine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and PharmaEngine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and PharmaEngine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Biotechnology and PharmaEngine, you can compare the effects of market volatilities on Medigen Biotechnology and PharmaEngine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of PharmaEngine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and PharmaEngine.

Diversification Opportunities for Medigen Biotechnology and PharmaEngine

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Medigen and PharmaEngine is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and PharmaEngine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmaEngine and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with PharmaEngine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmaEngine has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and PharmaEngine go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and PharmaEngine

Assuming the 90 days trading horizon Medigen Biotechnology is expected to generate 3.09 times less return on investment than PharmaEngine. But when comparing it to its historical volatility, Medigen Biotechnology is 1.28 times less risky than PharmaEngine. It trades about 0.06 of its potential returns per unit of risk. PharmaEngine is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  9,410  in PharmaEngine on November 27, 2024 and sell it today you would earn a total of  2,090  from holding PharmaEngine or generate 22.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Medigen Biotechnology  vs.  PharmaEngine

 Performance 
       Timeline  
Medigen Biotechnology 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Biotechnology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Medigen Biotechnology may actually be approaching a critical reversion point that can send shares even higher in March 2025.
PharmaEngine 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in PharmaEngine are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, PharmaEngine showed solid returns over the last few months and may actually be approaching a breakup point.

Medigen Biotechnology and PharmaEngine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medigen Biotechnology and PharmaEngine

The main advantage of trading using opposite Medigen Biotechnology and PharmaEngine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, PharmaEngine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmaEngine will offset losses from the drop in PharmaEngine's long position.
The idea behind Medigen Biotechnology and PharmaEngine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamental Analysis
View fundamental data based on most recent published financial statements
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules